Ann Thorac Surg 1994;58:312-320
© 1994 The Society of Thoracic Surgeons
Articles
Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia
Chris K. Rokkas, MD,
Loring R. Helfrich, Jr, BS,
Douglas C. Lobner, PhD,
Dennis W. Choi, MD, PhD,
Nicholas T. Kouchoukos, MD*
Division of Cardiothoracic Surgery, Department of Surgery, and Department of Neurology, Washington University School of Medicine, St. Louis, Missouri USA
* Address reprint requests to Dr Kouchoukos Department of Surgery, Jewish Hospital at Washington University Medical Center, 21th S Kingshighway Blvd, St. Louis, MO 63110-1013.
 |
Abstract
|
|---|
The release of excitatory amino acids, particularly glutamate, into the extracellular space plays a causal role in irreversible neuronal damage after central nervous system ischemia. Dextrorphan, a noncompetitive N-methyl-D-aspartate receptor antagonist, has been shown to provide significant protection against cerebral damage after focal ischemia. We investigated the changes in extracellular neutotransmitter amino acid concentrations using in vivo microdialysis in a swine model of spinal cord ischemia. After lumbar laminectomies were performed, all animals underwent left thoracotomy and right atrialfemoral cardiopulmonary bypass with additional aortic arch perfusion. Microdialysis probes were then inserted stereotactically into the lumbar spinal cord. The probes were perfused with artificial cerebrospinal fluid and 15-minute samples were assayed using high-performance liquid chromatography. Group 1 animals (n = 9) underwent aortic clamping distal to the left subclavian and proximal to the renal arteries for 60 minutes. Group 2 animals (n = 7) were treated with dextrorphan before application of aortic clamps, and during aortic occlusion and reperfusion. Five amino acids were studied, including two excitatory neurotransmitters (glutamate and aspartate) and three putative inhibitory neurotransmitters (glycine,
-amino-butyric acid, and serine). Somatosensory-evoked potentials and motor-evoked potentials were monitored. Glutamate exhibited a threefold increase in extracellular concentration during normothermic ischemia compared with baseline values and remained elevated until 60 minutes after reperfusion. In animals treated with dextrorphan, glutamate concentrations decreased to one-third of baseline levels before aortic clamping and remained unchanged during ischemia and reperfusion. There was early loss of somatosensory-evoked potentials and motor-evoked potentials during ischemia in group 1 animals. Group 2 animals demonstrated unchanged somatosensory-evoked potentials and only mild (20%) decrease in the amplitude of motor-evoked potentials. These results suggest that dextrorphan inhibits the release of excitatory amino acids in the spinal cord during ischemia and, therefore, may have a protective effect on spinal cord function during operations on the thoracoabdominal aorta.
 |
Footnotes
|
|---|
Presented at the Thirtieth Annual Meeting of the Society of Thoracic Surgeons, New Orleans, LA, Jan 31–Feb 2, 1994.

This study was supported in part by grants from the Shoenberg Foundation and Hoffman-LaRoche.
 |
References
|
|---|
- Graham LT, Shank RP, Werman R, Aprison MH. Distribution of some synaptic transmiller suspects in cat spinal cord: glutamic acid, aspartic acid, gamma-amino butyric acid, glycine, and glutamine J Neurochem 1967;14:465-472.[Medline]
- Fagg GE, Foster AC. Amino acid neurotransmitters and their pathways in the mammalian central nervous system Neuroscience 1983;9:701-719.[Medline]
- Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brair damage Ann Neurol 1986;19:105-111.[Medline]
- Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death Annu Rev Neurosci 1990;13:171-182.[Medline]
- Benveniste H, Drejer I, Sehousboe A, Diemer NH. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis J Neurochem 1984;43:1369-1374.[Medline]
- Globus MYT, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg, MD. Effect of the ischemia of the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis J Neurochem 1988;51:1455-1464.[Medline]
- Choi DW, Maulucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture J Neurosci 1987;7:357-368.[Abstract]
- Faden AI, Simon RP. A potential role for excitotoxins in the pathophysiology of spinal cord injury Ann Neurol 1988;23:623-626.[Medline]
- Simpson RK, Robertson CS, Goodman JC. Spinal cord ischemia-induced elevation of amino-acids: extracellular measurement with microdialysis Neurochem Res 1990;15:635-639.[Medline]
- Regan RF, Choi DW. Glutamate neurotoxicity in spinal cord cell culture Neuroscience 1991;43:585-591.[Medline]
- Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor Trends Neurosci 1987;10:299-302.
- Watkins JC, Olverman HJ. Agonists and antagonists for excitatory ammo acid receptors Trends Neurosci 1987;10:265-272.
- Diemer NH, Valente E, Bruhn T, Berg M, Jorgensen MB, Johansen FF. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms Prog Brain Res 1993;96:105-123.[Medline]
- Kochhar A, Zivin JA, Lyden PD, Mazzarella V. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia Arch Neurol 1988;45:148-153.[Medline]
- Kemp JA, Foster AC, Wong EHF. Non-competitive antagonists of excitatory amino acid receptors Trends Neurosci 1987;10:294-298.
- Goldberg MP, Pham PH, Choi DW. Dextrorphan and dextromethorphan attenuate hypoxic injury in neuronal culture Neurosci Lett 1987;80:11-15.[Medline]
- Choi DW. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity Brain Res 1987;403:333-336.[Medline]
- Sleinberg GK, Saleh J, DeLaPaz R, Kunis D, Zarnegar SR. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits Brain Res 1989;497:382-386.[Medline]
- Faden AI, Ellison JA, Noble LJ. Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury Eur J Pharm 1990;175:165-174.[Medline]
- Rokkas CK, Sundaresan S, Shuman TA, et al. Profound systemic hypothermia protects the spinal cord in a primate model of spinal cord ischemia J Thorac Cardiovasc Surg 1993;106:1024-1035.[Abstract]
- Benveniste H. Brain microdialysis J Neurochem 1989;52:1667-1679.[Medline]
- Van Wylen DGL, Park TS, Rubio R, Berne RM. Increases in cerebral interstitial fluid adenosine cuncentration during hypoxia, focal potassium infusion, and ischemia J Cereb Blood Flow Metab 1986;6:522-528.[Medline]
- Cohen SA, Bidlingmeyer BA, Tarvin TL. PITC derivatives in amino acid analysis Nature 1986;320:769-770.[Medline]
- Laschinger JC, Owen J, Rosenbloom M, Cox JL, Kouchoukos NT. Direct noninvasive monitoring of spinal cord motor function during thoracic aortic occlusion: use of motor evoked potentials J Vasc Surg 1988;7:161-171.[Medline]
- Olney ]W. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate Science 1969;164:719-721.[Abstract/Free Full Text]
- Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death J Neurosci 1984;4:1884-1891.[Abstract]
- Benveniste H. The excitotoxin hypothesis in relation to cerebral ischemia Cerebrovasc Brain Metab Rev 1991;3:213-245.[Medline]
- Ogura A, Miyamoto M, Kudo Y. Neuronal death in vitro: parallelism between survivabilily of hippocampal neurons and sustained elevation of cylosolic call after exposure to glutamate receptor agonist Exp Brain Res 1988;73:447-458.[Medline]
- Choi DW. NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation Prog Brain Res 1993;96:137-143.[Medline]
- Church J, Lodge D, Berry SC. Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids Eur J Pharm 1985;111:185-190.[Medline]
- Benson WM, Stefko PL, Randall LO. Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers J Pharmacol Exp Ther 1953;109:189-200.[Abstract/Free Full Text]
- Globus MY-T, Busto R, Martinez E, Valdes I, Dietrich WD, Ginsberg, MD. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerabte brain regions in the rat J Neurochcm 1991;57:470-478.
- Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes Science 1988;241:835-837.[Abstract/Free Full Text]
- Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 1987;325:529-531.[Medline]
- Patel J, Zinkand WC, Thomson C, Keith R, Salama A. Role of glycine in N-niethyl-D-aspartate-mediated neuronal cytotoxicity J Neurochem 1990;54:849-854.[Medline]
- In: Roberts E, Chase TN, Tower DB, editors. GABA in nervous system function. New York: Raven; 1976.
- Mayer ML, Westbrook GL. The physiology of excitatory amino acids in the vertebrate central nervous system Prog Neurobiol 1987;28:197-276.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
C. S. Isbir, K. Ak, O. Kurtkaya, U. Zeybek, S. Akgun, B. W. Scheitauer, A. Sav, and A. Cobanoglu
Ischemic preconditioning and nicotinamide in spinal cord protection in an experimental model of transient aortic occlusion
Eur J Cardiothorac Surg,
June 1, 2003;
23(6):
1028 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Terada, T. Kazui, M. Takinami, K. Yamashita, N. Washiyama, and B. A. H. Muhammad
Reduction of ischemic spinal cord injury by dextrorphan: Comparison of several methods of administration
J. Thorac. Cardiovasc. Surg.,
November 1, 2001;
122(5):
979 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Y. P. Wan, G. D. Angelini, A. J. Bryan, I. Ryder, and M. J. Underwood
Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery
Eur J Cardiothorac Surg,
February 1, 2001;
19(2):
203 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Cho, T. Ueda, A. Mori, T. Nakamichi, H. Shimizu, Y. Inoue, and S. Kawada
Exogenous aspartate neurotoxicity in the spinal cord under metabolic stress in vivo
Ann. Thorac. Surg.,
November 1, 2000;
70(5):
1496 - 1500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lang-Lazdunski, C. Heurteaux, A. Mignon, J. Mantz, C. Widmann, J.-M. Desmonts, and M. Lazdunski
Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole
Eur J Cardiothorac Surg,
August 1, 2000;
18(2):
174 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Gangemi, J. A. Kern, S. D. Ross, K. S. Shockey, I. L. Kron, and C. G. Tribble
Retrograde perfusion with a sodium channel antagonist provides ischemic spinal cord protection
Ann. Thorac. Surg.,
June 1, 2000;
69(6):
1744 - 1748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Killen, C. L. Weinstein, and W. A. Reed
Reversal of spinal cord ischemia resulting from aortic dissection
J. Thorac. Cardiovasc. Surg.,
May 1, 2000;
119(5):
1049 - 1052.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. D. Ross, J. A. Kern, J. J. Gangemi, C. R. St Laurent, K. S. Shockey, I. L. Kron, and C. G. Tribble
HYPOTHERMIC RETROGRADE VENOUS PERFUSION WITH ADENOSINE COOLS THE SPINAL CORD AND REDUCES THE RISK OF PARAPLEGIA AFTER THORACIC AORTIC CLAMPING
J. Thorac. Cardiovasc. Surg.,
March 1, 2000;
119(3):
588 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lang-Lazdunski, K. Matsushita, L. Hirt, C. Waeber, J.-P. G. Vonsattel, M. A. Moskowitz, and W. D. Dietrich
Spinal Cord Ischemia : Development of a Model in the Mouse Editorial Comment: Development of a Model in the Mouse
Stroke,
January 1, 2000;
31(1):
208 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Scarisbrick, P. J. Isackson, and A. J. Windebank
Differential Expression of Brain-Derived Neurotrophic Factor, Neurotrophin-3, and Neurotrophin-4/5 in the Adult Rat Spinal Cord: Regulation by the Glutamate Receptor Agonist Kainic Acid
J. Neurosci.,
September 15, 1999;
19(18):
7757 - 7769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Kouchoukos and C. K. Rokkas
Hypothermic cardiopulmonary bypass for spinal cord protection: rationale and clinical results
Ann. Thorac. Surg.,
June 1, 1999;
67(6):
1940 - 1942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lang-Lazdunski, C. Heurteaux, N. Vaillant, C. Widmann, and M. Lazdunski
RILUZOLE PREVENTS ISCHEMIC SPINAL CORD INJURY CAUSED BY AORTIC CROSSCLAMPING
J. Thorac. Cardiovasc. Surg.,
May 1, 1999;
117(5):
881 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Follis, K. S. Blisard, P. S. Varvitsiotis, S. B. Pett Jr, R. T. Temes, and J. A. Wernly
Selective protection of gray and white matter during spinal cord ischemic injury
Ann. Thorac. Surg.,
May 1, 1999;
67(5):
1362 - 1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ehrlich, E. Knolle, R. Ciovica, P. Bock, E. Turkof, M. Grabenwoger, F. Cartes-Zumelzu, A. Kocher, H. Pockberger, W. C. Fang, et al.
MEMANTINE FOR PREVENTION OF SPINAL CORD INJURY IN A RABBIT MODEL
J. Thorac. Cardiovasc. Surg.,
February 1, 1999;
117(2):
285 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Brock, J. M. Redmond, S. Ishiwa, M. V. Johnston, W. A. Baumgartner, J. C. Laschinger, and G. M. Williams
Clinical Markers in CSF for Determining Neurologic Deficits After Thoracoabdominal Aortic Aneurysm Repairs
Ann. Thorac. Surg.,
October 1, 1997;
64(4):
999 - 1003.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Mori, T. Ueda, T. Nakamichi, M. Yasudo, R. Aeba, H. Odaguchi, A. Mitsumaru, T. Ito, R. Yozu, A. Koto, et al.
Detrimental Effects of Exogenous Glutamate on Spinal Cord Neurons During Brief Ischemia In Vivo
Ann. Thorac. Surg.,
April 1, 1997;
63(4):
1057 - 1062.
[Abstract]
[Full Text]
|
 |
|